ArticleJournal of virology2015
Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.
Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Emergence of a novel GII.17 variant is associated with immune evasion rather than an altered HBGA-binding profile.PLoS pathogens · 2026Article
- Balancing under constraint: Structural insights into norovirus evolution and antigenic innovation.PLoS pathogens · 2026Article
- Harnessing marine sulfated polysaccharides to inhibit norovirus: from seaweed to solution.Microbiology spectrum · 2026Article
- GII.17 norovirus re-emerged in the 2020s as a result of dynamic and adaptive evolutionary processes.Nature communications · 2025Article
- Appearance and spread of norovirus genotype GII.17 subcluster C2 (Romania-2021 like) in Nizhny Novgorod, Russia, 2021-2023.Archives of virology · 2025Article
- Article
- Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.Journal of virology · 2024Article
- Rapid screening for antigenic characterization of GII.17 norovirus strains with variations in capsid gene.Gut pathogens · 2022Article
- Epidemiological Impact of GII.17 Human Noroviruses Associated With Attachment to Enterocytes.Frontiers in microbiology · 2022Article
- Identification of a blockade epitope of human norovirus GII.17.Emerging microbes & infections · 2021Article
- Glycan-Induced Protein Dynamics in Human Norovirus P Dimers Depend on Virus Strain and Deamidation Status.Molecules (Basel, Switzerland) · 2021Article
- Fondness for sugars of enteric viruses confronts them with human glycans genetic diversity.Human genetics · 2020Review
- Recent advances in human norovirus research and implications for candidate vaccines.Expert review of vaccines · 2020Review
- Molecular and evolutionary characterization of norovirus GII.17 in the northern region of Brazil.BMC infectious diseases · 2019Article
- Review
- Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.Journal of virology · 2019Article
- Structural Basis for Human Norovirus Capsid Binding to Bile Acids.Journal of virology · 2019Article
- Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths.Journal of virology · 2019Article
- Atomic Structure of the Murine Norovirus Protruding Domain and Soluble CD300lf Receptor Complex.Journal of virology · 2018Article
- The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity.Molecules (Basel, Switzerland) · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent reports suggest that human genogroup II genotype 17 (GII.17) noroviruses are increasing in prevalence. We analyzed the evolutionary changes of three GII.17 capsid protruding (P) domains. We found that the GII.17 P domains had little cross-reactivity with antisera raised against the dominant GII.4 strains. X-ray structural analysis of GII.17 P domains from 2002 to 2014 and 2015 suggested that surface-exposed substitutions on the uppermost part of the P domain might have generated a novel 2014-2015 GII.17 variant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.